These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21395474)

  • 1. Necessity of level IV dissection in cN0 hypopharyngeal carcinoma.
    Shin YS; Kim SH; Koh YW; Hong HJ; Seol JH; Choi EC
    Acta Otolaryngol; 2011 Jun; 131(6):665-9. PubMed ID: 21395474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic selective neck dissection (level II-V) for node-positive hypopharyngeal carcinoma: is it oncologically safe?
    Lim YC; Lee JS; Choi EC
    Acta Otolaryngol; 2009 Jan; 129(1):57-61. PubMed ID: 18607981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is it necessary to dissect levels I and IIB in hypopharyngeal cancer?
    Wiegand S; Esters J; Müller HH; Jäcker T; Roessler M; Werner JA; Sesterhenn AM
    Acta Otolaryngol; 2010 Jun; 130(6):747-52. PubMed ID: 19968609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is dissection of level IV absolutely necessary in elective lateral neck dissection for clinically N0 laryngeal carcinoma?
    Lim YC; Choi EC; Lee JS; Koo BS; Song MH; Shin HA
    Oral Oncol; 2006 Jan; 42(1):102-7. PubMed ID: 16143563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of therapeutic (N1, N2) selective neck dissection (levels II to V) in patients with laryngeal and hypopharyngeal squamous cell carcinoma.
    Lohuis PJ; Klop WM; Tan IB; van Den Brekel MW; Hilgers FJ; Balm AJ
    Am J Surg; 2004 Feb; 187(2):295-9. PubMed ID: 14769324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic metastases to level IIb in hypopharyngeal squamous cell carcinoma.
    Kim YH; Koo BS; Lim YC; Lee JS; Kim SH; Choi EC
    Arch Otolaryngol Head Neck Surg; 2006 Oct; 132(10):1060-4. PubMed ID: 17043251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is dissection of levels 4 and 5 justified for cN0 laryngeal and hypopharyngeal cancer?
    Katilmiş H; Oztürkcan S; Ozdemir I; Tuna B; Güvenç IA; Ozkul Y
    Acta Otolaryngol; 2007 Nov; 127(11):1202-6. PubMed ID: 17851904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neck dissection of Levels II and III for the treatment of supraglottic laryngeal cancer with clinically negative neck].
    Jia SS; Wang YY; He HJ; Xiang C
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Sep; 45(9):747-50. PubMed ID: 21092673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of contralateral N0 neck in pyriform sinus carcinoma.
    Koo BS; Lim YC; Lee JS; Kim YH; Kim SH; Choi EC
    Laryngoscope; 2006 Jul; 116(7):1268-72. PubMed ID: 16826073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for the N0 neck.
    Lim YC; Koo BS; Lee JS; Lim JY; Choi EC
    Laryngoscope; 2006 Jul; 116(7):1148-52. PubMed ID: 16826050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation of cervical lymphatic metastasis to prognosis of T3-T4 glottic cancer].
    Yu WB; Zeng ZY; Chen FJ; Zhang Q; Guo ZM; Li H; Liu XK; Wu GH
    Ai Zheng; 2006 Oct; 25(10):1271-4. PubMed ID: 17059774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Level IIb lymph node metastasis in elective neck dissection of oropharyngeal squamous cell carcinoma.
    Lee SY; Lim YC; Song MH; Lee JS; Koo BS; Choi EC
    Oral Oncol; 2006 Nov; 42(10):1017-21. PubMed ID: 16757201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Level V lymph node dissection in oral and oropharyngeal carcinoma patients with clinically node-positive neck: is it absolutely necessary?
    Lim YC; Koo BS; Lee JS; Choi EC
    Laryngoscope; 2006 Jul; 116(7):1232-5. PubMed ID: 16826066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: a subset analysis of the University of Pennsylvania transoral robotic surgery trial.
    Weinstein GS; Quon H; O'Malley BW; Kim GG; Cohen MA
    Laryngoscope; 2010 Sep; 120(9):1749-55. PubMed ID: 20717944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective neck dissection (IIA, III): a rational replacement for complete functional neck dissection in patients with N0 supraglottic and glottic squamous carcinoma.
    Ferlito A; Silver CE; Rinaldo A
    Laryngoscope; 2008 Apr; 118(4):676-9. PubMed ID: 18182969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective neck dissection for node-positive necks in patients with head and neck squamous cell carcinoma: a word of caution.
    Santos AB; Cernea CR; Inoue M; Ferraz AR
    Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):79-81. PubMed ID: 16415434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elective lateral neck dissection for laryngeal cancer in the clinically negative neck.
    Zhang B; Xu ZG; Tang PZ
    J Surg Oncol; 2006 May; 93(6):464-7. PubMed ID: 16615158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of contralateral N0 neck in early squamous cell carcinoma of the oral tongue: elective neck dissection versus observation.
    Lim YC; Lee JS; Koo BS; Kim SH; Kim YH; Choi EC
    Laryngoscope; 2006 Mar; 116(3):461-5. PubMed ID: 16540910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Level IIb lymph node metastasis in laryngeal squamous cell carcinoma.
    Lim YC; Lee JS; Koo BS; Choi EC
    Laryngoscope; 2006 Feb; 116(2):268-72. PubMed ID: 16467717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neck recurrence after level I-IV or I-III selective neck dissection in the management of the clinically N0 neck in patients with oral squamous cell carcinoma.
    Bajwa MS; McMillan R; Khattak O; Thomas M; Krishnan OP; Webster K
    Head Neck; 2011 Mar; 33(3):403-6. PubMed ID: 20629073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.